Garrib, Anupam
Kivuyo, Sokoine
Bates, Katie
Ramaiya, Kaushik
Wang, Duolao
Majaliwa, Edna
Simbauranga, Rehema
Charles, Godbless
van Widenfelt, Erik
Luo, Huanyan
Alam, Uazman
Nyirenda, Moffat J.
Jaffar, Shabbar
Mfinanga, Sayoki
,
Funding for this research was provided by:
Public Health Research Programme (16/137/87)
Article History
Received: 14 February 2023
Accepted: 12 May 2023
First Online: 18 July 2023
Acknowledgements
: We thank staff at Merck, in particular K. Brand (Merck, Darmstadt, Germany), for the supply of products, the Ministry of Health in Tanzania, and T. Chen (LSTM, Liverpool, UK; present affiliation: University of York, York, UK) for support with generation of the participant randomisation list.
: The data that support the findings of this study are not openly available due to reasons of sensitivity and are available from the corresponding author upon reasonable request and with the permission of the RESPOND-Africa partnership.
: This research was funded by the National Institute for Health Research (NIHR; project reference 16/137/87) using UK aid from the UK Government to support global health research. The views expressed in this publication are those of the authors and not necessarily those of the NIHR or the UK Department of Health and Social Care. KB was partially supported by an FWF (Fonds zur Förderung der wissenschaftlichen Forschung) Austrian Science Fund Lise Meitner Award (M-3069-B). The trial funder, suppliers and drug manufacturer had no role in the study design, data collection, analysis, interpretation or manuscript preparation. The corresponding author had full access to all of the data used in the study and had final responsibility for the decision to submit for publication.
: The authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.
: MJN and KR conceived the idea, and MJN and SJ led the design of the study with input from AG, SK and SM. AG and SK co-ordinated the study, and AG wrote the first draft of the paper with input from SK. KB, DW and HL conducted the statistical analysis. SJ, MJN, KR, UA, AG, SM and KB interpreted the findings. KR was the senior trial diabetologist and clinician, supported by UA. EM, RS and GC were the lead researchers at each site and were involved in recruitment, management and follow up of participants. SM oversaw all activity in Tanzania. EvW managed the data with input from AG, KB and SK. SJ co-ordinated the final write-up of the article with input and revisions from AG, KR, UA, MJN, SM, KB, DW, EM, RS, GC, HL and EvW on different parts of the article. All authors saw and approved the final version of the manuscript. AG is responsible for the integrity of this work as a whole.